Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Feb;33(2):327-342.
doi: 10.1038/s41433-018-0303-0. Epub 2018 Dec 12.

Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom

Affiliations
Comment

Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom

Jonathan C P Roos et al. Eye (Lond). 2019 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Comment on

Similar articles

Cited by

References

    1. Wong Y, Dickinson J, Perros P, Dayan C, Veeramani P, Morris D, et al. A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom. Eye. 2018;32:1555–62. doi: 10.1038/s41433-018-0144-x. - DOI - PMC - PubMed
    1. Perros P, Hegedius L, Bartalena L, Marocci C, Kahaly GJ, Baldeschi L, et al. Graves’ Orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis. 2017;12:72. doi: 10.1186/s13023-017-0625-1. - DOI - PMC - PubMed
    1. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, et al. European Group on Graves’ Orbitopathy (EUGOGO). Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158:273–85. doi: 10.1530/EJE-07-0666. - DOI - PubMed
    1. Roos JCP, Paulpandian V, Murthy R. Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy.Eye (Lond). 2018 Nov 6. doi: 10.1038/s41433-018-0242-9. [Epub ahead of print] - PMC - PubMed